On August 19, 2026, the U.S. Court of Appeals for the Fifth Circuit issued a published opinion granting petitions for review in seven consolidated cases, vacating FDA’s Premarket Tobacco Product Application (PMTA) marketing denial orders (MDOs) for each manufacturer petitioner’s electronic nicotine delivery system (ENDS) products, and remanding the PMTAs back to the agency for

Keller and Heckman Partner Eric Gotting was interviewed on the recent episode of Regulator Watch (RegWatch), “Major Win | Court Ruling Could Dismantle FDA’s Flavored Vape Ban.” The episode discusses the recent Fifth Circuit ruling that FDA violated the Administrative Procedure Act when it imposed its comparative-efficacy standard without notice-and-comment rulemaking.

To watch the full

On June 30, 2026, FDA issued modified risk granted orders to Swedish Match USA, Inc., a wholly owned subsidiary of Philip Morris International Inc., for 20 ZYN nicotine pouch products, authorizing the company to market those products with the claim: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart

On June 26, 2026, the U.S. Food and Drug Administration (FDA), Center for Tobacco Products (CTP), announced a proposed rule titled “Establishment Registration and Product Listing for Tobacco Products” that, if finalized, would require foreign tobacco product manufacturing establishments to register with FDA and list tobacco products manufactured for import into the United

On April 23, 2026, Maine enacted Public Law Chapter 769, An Act to Create a Stewardship Program for Electronic Smoking Devices and Related Products, codified at 38 M.R.S.A. § 1618. The law appears to make Maine the first U.S. state to enact an extended producer responsibility (EPR) law specifically targeting “electronic smoking devices.” Once the

On 18 May 2026, the European Commission launched a call for evidence related to the upcoming revision of EU Tobacco Products Directive 2014/40/EU (TPD). Feedback is open until 15 June 2026 and is open to everybody. In the meantime, public consultation, available to stakeholders including citizens, businesses, representative organisations and EU countries’ public authorities, academics

At Keller and Heckman’s recent 10th Annual E-Vapor, Nicotine, and Tobacco Law Symposium in Las Vegas, Nevada, Partners Azim Chowdhury, David Ettinger, and Katie Skaggs—along with several guest speakers—were featured in RegWatch Briefs, a series hosted by Brent Stafford. The series spotlights concise discussions on key issues in the nicotine and tobacco space, including

On May 8, 2026, the U.S. Food and Drug Administration (FDA) issued final guidance describing how the Agency intends to prioritize enforcement for certain unauthorized electronic nicotine delivery systems (ENDS) and oral nicotine pouch products marketed without premarket authorization. The guidance is effective immediately and replaces FDA’s prior April 2020 ENDS enforcement-priorities guidance.

Critically

On May 5, 2026, the U.S. Food and Drug Administration (FDA) issued marketing granted orders (MGOs) for four Glas closed-pod electronic nicotine delivery system (ENDS) products: Classic Menthol, Fresh Menthol, Gold (mango), and Sapphire (blueberry). The authorization is a significant development for the ENDS industry because the Gold and Sapphire are FDA’s first authorized non-tobacco

Keller and Heckman Tobacco and E-Vapor attorneys, led by Partner Azim Chowdhury, co-authored with Latham & Watkins the Food and Drug Law Institute (FDLI) 2026 publication, “Nicotine Delivery Products: Navigating FDA’s Policies and Regulations in a Dynamic Environment.” Counsel Neelam Gill and LieAnn Van-Tull also served as co-authors, while the following Keller and Heckman attorneys